Upload
iulia-butoi
View
220
Download
0
Embed Size (px)
Citation preview
8/13/2019 Dieta la animale
1/7
DIETARY-RESPONSIVE DISEASE
EtiologyDietary-responsive disease is an all-inclusive term thatincludes dietary allergy (a hyperimmune response to a
dietary antigen) and dietary intolerance (a nonimmune
mediated response to a dietary substance). From a clinical
standpoint, there is minimal value in distinguishing betweenthe two unless there are concurrent cutaneous signs of allergic
disease.
Clinical FeaturesAffected patients may have vomiting and/or diarrhea (largeand/or small bowel) as well as allergic skin disease.
Diagnosisiagnosis consists of showing response to feeding an elimination
diet that is appropriate for the patient (see the discussion
of dietary management in !hapter "#). $here is typicallyminimal value in distinguishing between allergy and intolerance.
$ests for %g& antibodies i n the patient's blood to specific
antigens are not as valuable as seeing the response to an
elimination diet. $he diet must be carefully chosen it must
consist of nonallergenic substances or foods to which thepatient has not previously been eposed. *ost animals
respond to an appropriate diet within " weeks, although
some take longer.
Treatment*ost patients that respond can simply be fed the diet towhich they responded in the dietary trial (assuming that it
is balanced). +are patients develop allergies to the elimination
diet and reuire different elimination diets to be fed on
rotating - to "-week cycles.
Prognosis$he prognosis is usually good.
SMALL INTESTINAL INFLAMMATORY
BOWEL DISEASE
Clinical Features% involves idiopathic intestinal inflammation. % canaffect any portion of the canine or feline intestine. Although
the cause of % is unknown, it is speculated to involve aneaggerated or inappropriate response by the immune system
to bacterial and/or dietary antigens as at least part of themechanism. $he clinical and histologic features of % can
closely resemble those of alimentary lymphoma (see p. 01).
2ymphocytic-plasmacytic enteritis (23&) is the most commonlydiagnosed form of canine and feline %. !hronic
small intestinal diarrhea is common, but some patients have
weight loss with normal stools. %f the duodenum is severely
affected, vomiting may be the ma4or sign, and diarrhea can
be either mild or absent. 3rotein-losing enteropathy canoccur with the more severe forms.
&osinophilic gastroenterocolitis (&5&) is usually an allergic
reaction to dietary substances (e.g., beef, milk) and as
such is not %. 6owever, the clinical signs do not always
respond to dietary change and may represent true % insome dogs. %t is less common than 23&. 7ome cats have
eosinophilic enteritis as part of a hypereosinophilic syndrome
(6&7). $he cause of feline 6&7 is unknown, but
immune-mediated and neoplastic mechanisms may beresponsible. 2ess severely affected cats without 6&7 seem tohave a condition similar to canine &5&.
Diagnosisecause % is idiopathic intestinal inflammation, it is adiagnosis of eclusion it is not 4ust a histologic diagnosis.
8o physical eamination, historic, clinical pathology,imaging, or histologic findings are diagnostic of %. iagnosis
reuires elimination of known causes of diarrhea
plus histology showing mucosal inflammatory infiltrates,
architectural changes (e.g., villus atrophy, crypt changes),
8/13/2019 Dieta la animale
2/7
and/or epithelial changes. *ucosal cytologic evaluation is
unreliable for diagnosing lymphocytic inflammation because
lymphocytes and plasma cells are normally present in intestinal
mucosa. 6istologic diagnosis of mucosal inflammation
is unfortunately sub4ective, and biopsy samples are freuentlyoverinterpreted. 9 * i l d 9 23& often refers to essentially normal
tissue. &ven descriptions of 9moderate9 or 9severe9 23& may
be dubious because of substantial inconsistency among
pathologists. %t can be etremely difficult to distinguish awell-differentiated lymphocytic lymphoma from severe 23&,even with full-thickness samples. 7ome animals with intense
dietary reactions have biopsy findings that resemble lymphoma.
%f the biopsy specimens are of marginal uality
(either from the standpoint of si:e or artifacts present), it is
easy to mistakenly diagnose 23& instead of lymphoma if thelatter is causing a secondary tissue reaction. +ecent data
document that biopsy of more than one site (e.g., duodenum
and ileum, as opposed to 4ust duodenum) is sometimes
critical in finding inflammatory (and neoplastic) changes.
iagnosis of feline 23& is similar to that of canine 23&, butit is important to note that cats with % may have mild to
moderate mesenteric lymphadenopathy, and such lymph
adenopathy is not diagnostic of intestinal lymphoma.
iagnosis of &5& is similar to diagnosis of 23&. ogs
with &5& may have eosinophilia and/or concurrent eosinophilic
respiratory or cutaneous dietary allergies with pruritus.5erman 7hepherd dogs seem to be overrepresented.iagnosis of feline &5& centers on finding intestinal eosinophilic
infiltrates however, splenic, hepatic, lymph node,
and bone marrow infiltrates and peripheral eosinophilia are
common.
Treatment!anine 23& treatment begins with elimination diets and
antibiotics in case what appears to be % is actually dietary
intolerance or A+&. ;ther therapy depends on the severity
of the 23&. 7omewhat more severe disease warrants
metronida:ole with or without high-dose corticosteroidtherapy (e.g., prednisolone, . mg/kg/day or budesonide in
steroid-intolerant patients). *ore severe disease, especially if
associated with hypoalbuminemia, usually reuires immunosuppressives
(e.g., a:athioprine or cyclosporine). !yclosporine
seems to be reasonably effective and works fasterthan a:athioprine administered every other day however, it
is also more epensive. &lemental diets, although epensive,
can be invaluable in severely emaciated or severely hypoproteinemic patients with severe inflammation as a way to feed
the patient and the intestinal mucosa without causing more
mucosal irritation. Failure of a dog to respond to 9appropriate9
therapy can be the result of inadeuate therapy, owner
noncompliance, or misdiagnosis (i.e., diagnosing 23& whenthe problem is lymphoma).
Feline 23& treatment is somewhat similar to that for
canine 23&. 6ighly digestible elimination diets may be curative
if what was thought to be % is actually food intolerance,
and therapeutic diets should always be used i f the catwill eat them. 6igh doses of corticosteroids are typically
administered early in cats because of their beneficial effects
and the cat's relative resistance to iatrogenic hyperadreno
corticism. 3rednisolone is preferred to prednisone in the cat,and methylprednisolone is typically more effective than
prednisolone. udesonide is primarily indicated in cats that
cannot tolerate the systemic effects of steroids (e.g., thosewith diabetes mellitus). 2ow-dose metronida:ole (
8/13/2019 Dieta la animale
3/7
!hapter "#). 3arenteral administration of cobalamin to cats
with severely decreased serum concentrations may aid or be
necessary for remission of diarrhea. %f the cat responds to
this therapy, the elimination diet should be continued while
the medications are gradually tapered one at a time.!anine &5& treatment should focus on a strict hypoal
lergenic diet (e.g., fish and potato, turkey and potato). 3artiallyhydroly:ed diets may also be helpful, but they are not
a panacea for all 5% dietary allergies/intolerances. %t is importantto determine what the dog was fed previously when
selecting the dietary therapy. %f signs do not resolve with
dietary therapy, the addition of corticosteroid therapy isusually curative. Animals usually respond better to elimination
diets than to corticosteroids. 7ometimes, an animal i n i tially
responds to dietary management but relapses while still
eating this diet because it becomes allergic to one of the
ingredients. $his situation necessitates administration ofanother elimination diet. %n some animals that are very
prone to developing such intolerances, switching back and
forth from one elimination diet to another at -week intervals
helps to prevent this relapse from happening. (7ee
!hapter "# for more information on these therapies.)Feline &5& associated with hypereosinophilic syndrome
usually reuires high-dose corticosteroid therapy (i.e., prednisolone,
. to 0.0 mg/kg/day) response is often poor. !ats
with eosinophilic enteritis not caused by 6&7 often respondfavorably to elimination diets plus corticosteroid therapy.%f the dog or cat responds clinically, then the therapy
should be continued without change for another to weeks
to ensure that the clinical improvement is the result of the
therapy and not an unrelated transient improvement. ;nce
the clinician is convinced that the prescribed therapy isresponsible for the improvement seen, the animal should be
slowly weaned from the drugs, starting with those that have
the greatest potential for adverse effects. %f antiinflammatory
or immunosuppressive therapy was initially reuired, the
clinician should attempt to maintain the pet on every-otherdaycorticosteroid and a:athioprine therapy. %f that regimen
is successful, then the lowest effective dose of each should be
slowly determined. ;nly one change should be made at a
time, and the dose should not be decreased more freuently
than once every to " weeks, if possible. %f a homemade dietwas used initially, the clinician should seek to transition the
patient to a complete, balanced commercial elimination diet.
ietary and antibiotic therapy are usually the last to be
altered. $here is no obvious benefit to rebiopsying patients
that are clinically improving.
Prognosis$he prognosis for dogs and cats with 23& is often good, if
therapy is begun before the patient is emaciated. 7evere
hypoalbuminemia and a very poor body condition arethought to be suggestive that the patient may have more
difficulty responding. A markedly low serum cobalamin concentration
in the dog might be a poor prognostic sign, but
that is uncertain. *any animals will need to be on a special
diet for the rest of their lives. *any with moderate to severedisease will need prolonged medical therapy, which should
be tapered cautiously. %atrogenic !ushing's syndrome should
be avoided. 7everely affected animals may initially benefitfrom enteral or parenteral nutritional therapy. Although the
relationship is unclear, 23& has been suggested to be a potentiallyprelymphomatous lesion (see p. 0# for immunopro
liferative enteropathy in asen4is) however, this is uncertain.
%f a dog or cat with a prior diagnosis of 2 3& is later diagnosed
as having lymphoma, it may be 4ust as likely that either theinitial diagnosis of % was wrong (i.e., the patient had
lymphoma) or that the lymphoma developed independently
of the %.
LARGE INTESTINAL INFLAMMATORY
8/13/2019 Dieta la animale
4/7
BOWEL DISEASE
Clinical Features%n the author's practice, Clostridium colitis, parasites, dietaryintolerance, and fiber-responsive diarrhea are responsible
for most cases referred and previously diagnosed as having
9intractable9 large bowel 9%.9 !anine lymphocyticplasmacytic
colitis (23!) typically causes large bowel diarrhea
(i.e., soft stools with or without blood or mucus no
appreciable weight loss). %n general, affected dogs are fundamentallyhealthy ecept for soft stools. %n cats hematoche:ia
is the most common clinical sign, and diarrhea is the second
most common sign. Feline 2 3 ! may occur by itself or concurrently
with 23&, whereas canine large bowel % seemsto be infreuently associated with small bowel %.
Diagnosisiagnosis (i.e., ecluding other causes and finding mucosal
histologic changes) is similar to that for small bowel %. %n
particular, Tritrichomonas can cause substantial mononuclearinfiltrates into feline colonic mucosa.
Treatment7teroids, metronida:ole, sulfasala:ine (A:ulfidine), mesalamine, or olsala:ine may be used in dogs with moderate to
severe 23!. !orticosteroids and/or metronida:ole may be
effective by themselves and/or allow lower doses of sulfasala:ine
to be successful. 6ypoallergenic and fiber-enriched dietsare often very helpful. %t is critical to eliminate colonic fungalinfections before begining immunosuppressive therapy.
6igh-fiber and hypoallergenic diets are also often beneficial
in cats in fact, most 9intractable9 feline 2 3 ! cases seen
in the author's practice are ultimately determined to be related
to diet. *ost cats with 23! respond well to prednisoloneand/or metronida:ole, and sulfasala:ine is rarely needed.
Prognosis$he prognosis for patients with colonic % tends to be
better than for small bowel %.
GRANULOMATOUS ENTERITIS/
GASTRITIS
!anine granulomatous enteritis/gastritis is uncommon, and
it can be diagnosed only histopathologically. $he clinicianshould search diligently for an etiology (e.g., fungal). !linical
signs are similar to those of other forms of %. Althoughcompared to !rohn's disease in people, the two are dissimilar.
%f the disease is locali:ed, surgical resection should be
considered i f the clinician is sure that there is not a systemiccause (e.g., fungal). %f it is diffuse, corticosteroids, metronida:ole,
antibiotics, a:athioprine, and dietary therapy should
be considered. $oo few cases have been described and treated
to allow generali:ations. $he prognosis is poor.
Feline granulomatous enteritis is a rare type of % thatcauses weight loss, protein-losing enteropathy, and perhaps
diarrhea it also reuires histopathologic confirmation. Affected
cats seem to respond to high-dose corticosteroid therapy, but
attempts to reduce the dose of glucocorticoids may cause
recurrence of clinical signs. $he prognosis is guarded.
IMMUNOPROLIFERATIVE ENTEROPATHY
IN BASENJIS
Etiology%mmunoproliferative enteropathy in asen4is is an intense
lymphocytic-plasmacytic small intestinal infiltrate often
associated with villous clubbing, m i l d lacteal dilation, gastric
rugal hypertrophy, lymphocytic gastritis, and/or gastricmucosal atrophy. %t probably has a genetic basis or predisposition,
and intestinal bacteria may play an important role.
Clinical Features$he disease tends to be a severe form of 23& that waes and
wanes, particularly as the animal is stressed (e.g., traveling,disease). ?eight loss, small intestinal diarrhea, vomiting,
8/13/2019 Dieta la animale
5/7
and/or anoreia are commonly seen. *ost affected asen4is
start showing clinical signs by " to years of age.
Diagnosis*arked hypoalbuminemia and hyperglobulinemia are
common, especially in advanced cases. $he early stages ofthe disease resemble many other intestinal disorders. %n
advanced cases the clinical signs are so suggestive that a
presumptive diagnosis is often made without biopsy.
6owever, because other diseases (e.g., lymphoma, histoplasmosis)may mimic immunoproliferative enteropathy,alimentary tract biopsy is needed before aggressive immunosuppressive
therapy is begun.
Treatment$herapy may include highly digestible, elimination, or elementaldiets antibiotics for A+& (see p. =1) high-dose
corticosteroids metronida:ole and a:athioprine. +esponse
to therapy is variable, and affected dogs that respond are at
risk for relapse, especially if stressed.
Although a genetic basis is suspected, not enough isknown to be able to confidently recommend a breeding
program. 3erforming biopsy of the intestines of asymptomatic
dogs to identify animals in which the disease will develop
is dubious because clinically normal asen4is may have
lesions similar to those of dogs with diarrhea and weight loss,
although the changes tend to be milder.Prognosis*any affected animals die to " years after diagnosis. $he
prognosis is poor for recovery, but some dogs can be maintained
for prolonged periods of time with careful monitoringand care. %n a few dogs lymphoma later develops.
ENTEROPATHY IN CHINESE SHAR-PEIS
Etiology!hinese 7har-3eis have a poorly characteri:ed enteropathy
that may be uniue to them or may be a severe form of
%. !hinese 7har-3eis have immune system abnormalities
that may predispose them to eaggerated inflammatory
reactions.
Clinical Featuresiarrhea and/or weight loss (i.e., small intestinal dysfunction)
are the main clinical signs.
Diagnosis7mall intestinal biopsy is necessary for diagnosis. &osinophilic
and lymphocytic-plasmacytic intestinal infiltrates are
typically found. 7erum cobalamin concentrations are often
uite low.
Treatment$he animal is treated for % (i.e., elimination diets and
immunosuppressive drugs) and A+&.
PrognosisAffected !hinese 7har-3eis have a guarded prognosis.
PROTEIN-LOSING ENTEROPATHY
CAUSES OF PROTEIN-LOSING
ENTEROPATHY
Any intestinal disease that produces sufficient inflammation,infiltration, congestion, or bleeding can produce a proteinlosing
enteropathy (32& or gastropathy if it affects thestomach see o @-
8/13/2019 Dieta la animale
6/7
caused by 23& or lymphoma. $herapy should be directed at
managing the underlying cause.
INTESTINAL LYMPHANGIECTASIA
Etiology%ntestinal lymphangiectasia (%2) is a disorder of the intestinal
lymphatic system of dogs. 2ymphatic obstruction causes
dilation and rupture of intestinal lacteals with subseuent
leakage of lymphatic contents (i.e., protein, lymphocytes,
and chylomicrons) into the intestinal submucosa, laminapropria, and lumen. Although these proteins may be digested
and resorbed, ecessive loss eceeds the intestine's ability to
resorb them, thus resulting in hypoalbuminemia. 2eakage of
lymphatic fat into the intestinal wall may cause granulomaformation, which eacerbates lymphatic obstruction. 8ot
reported in cats, the condition has many potential causes in
dogs (e.g., lymphatic obstruction, pericarditis, infiltrative
mesenteric lymph node disease, infiltrative intestinal mucosal
disease, congenital malformations). *ost cases of symptomatic%2 are idiopathic.
Clinical Featuresorkshire $erriers, 7oft !oated ?heaten $erriers, and
2undehunds appear to be at higher risk than other breeds.
7oft !oated ?heaten $erriers also have an unusually highincidence of protein-losing nephropathy. $he first sign of
disease caused by %2 may be transudative ascites. iarrhea isinconsistent and may occur early or late i n the course of the
disease, if at all. %ntestinal lipogranulomas (i.e., white nodules
in the intestinal serosa or mesentery) are sometimes foundat surgery. $hey are probably secondary to %2 (i.e., fat leaking
out of dilated lymphatic vessels), but they might worsen
eisting %2 by further obstructing lymphatics.
Diagnosis!linical pathologic evaluation is not diagnostic, but hypoalbuminemia
and hypocholesterolemia are epected. Although
panhypoproteinemia is classically attributed to 32&, animals
that were initially hyperglobulinemic may lose most of their
serum proteins and still have normal serum globulin concentrations.2ymphopenia is common but inconsistent.
iagnosis reuires intestinal histopathology. Feeding the
animal fat the night before the biopsy seems to make lesions
more obvious, and classic mucosal lesions may be seen endo
scopically (Fig. ""-@). &ndoscopic biopsies are often diagnos-
FIG 33-8Endoscopic image of the duodenum of a dog with lymphangiectasiaThe large white !dots! are dilated lacteals in thetips of the "illi
tic if done appropriately, but surgical biopsies are sometimes
reuired. %f full-thickness surgical biopsies are performed,
serosal patch grafting and nonabsorbable suture material
may decrease the risk of dehiscence. %2 may be locali:ed toone area of the intestines (e.g., ileum).
Treatment$he underlying cause of %2 is rarely determined, necessitating
reliance on symptomatic therapy. A n ultra-low-fat diet
essentially devoid of long-chain fatty acids helps to preventfurther intestinal lacteal engorgement and subseuent
protein loss. 3rednisolone (
8/13/2019 Dieta la animale
7/7
therapy.
PROTEIN-LOSING ENTEROPATHY IN
SOFT-COATED WHEATEN TERRIERS
Etiology7oft !oated ?heaten $erriers (7!?$s) have a predisposition
to 32& and protein-losing nephropathy. $he cause uncertain, although food hypersensitivity has been reported
to be present in some affected dogs.
Clinical Features%ndividual dogs may have 32& or protein-losing nephropathy(or both). $ypical clinical signs may include vomiting,
diarrhea, weight loss, and ascites. Affected dogs are often
middle aged when diagnosed.
Diagnosis3anhypoproteinemia and hypocholesterolemia are common,
as with any 32&. 6istopathology of intestinal mucosa
may reveal lymphangiectasia, lymphangitis, or supposedly
%.
Treatment#Prognosis$reatment is typically as for lymphangiectasia and/or %.
$he prognosis appears guarded to poor for clinically i ll
animals, with most dying within a year of diagnosis.
FUNCTIONAL INTESTINAL DISEASE
IRRITABLE BOWEL SYNDROME
Etiology%rritable bowel syndrome (%7) i n people is characteri:ed bydiarrhea, constipation, and/or cramping (usually of the large
intestines) in which an organic lesion cannot be identified.
%t is an idiopathic large bowel disease in which all known
causes of diarrhea have been eliminated and a 9functional9
disorder is presumed. %7 in dogs is different and primarilyinvolves an idiopathic, chronic large bowel diarrhea in which
parasitic, dietary, bacterial, and inflammatory causes have
been eliminated. $here are probably various causes of this
syndrome in dogs.
Clinical Features!hronic large bowel diarrhea is the principal sign. Fecal
mucus is common, blood in the feces is infreuent, and
weight loss is very rare. 7ome dogs with %7 are small breeds
that are heavily imprinted on a single family member. !linical
signs may develop following separation of the dog fromthe favored person. ;ther dogs with %7 are nervous and
high-strung (e.g., police or guard dogs, especially 5erman
7hepherd ogs). 7ome dogs have no apparent initiating
cause.
Diagnosisiagnosis consists of eliminating known causes by physical
eamination, clinical pathologic data, fecal analysis, colonoscopy/
biopsy, and appropriately performed therapeutic trials.
Treatment$reatment with fiber-supplemented diets (i.e., B1C to >C
fiber on a dry matter basis) is often helpful (see p. ">@). *any
animals must receive fiber chronically to prevent relapse.
Anticholinergics occasionally are useful (e.g., propantheline,
#.= mg/kg or dicyclomine, #.